Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: A phase 2 randomized clinical trial.

Nat Commun · 2025 · PMC12084539 · PMID 40379675

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

did not reach statistical significanceP = 0.15not close (p > 0.1)

DALT was also lower in the PPM group than in the SOC group, but, because many subjects did not reach normal ALT levels prior to hospital discharge, this difference did not reach statistical significance (12.7 days for SOC vs. 8.0 days for PPM, P = 0.15).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.